Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05296655
Other study ID # 14-2020/1
Secondary ID
Status Completed
Phase
First received
Last updated
Start date March 1, 2020
Est. completion date February 16, 2022

Study information

Verified date May 2022
Source Kazakh Medical University of Continuing Education
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Reflux symptoms index (RSI) were developed to identify a clinical index of suspicion for laryngopharyngeal reflux (LPR) in patients with ear, nose, and throat symptoms. RSI is an efficient diagnostic tool for LPR/ It is easy to use, even for those who know little about LPR. It does not require special equipment or examinations and is inexpensive. Thus, it can be considered highly efficient and cost-effective. The study will focus on translating and testing the RSI into Kazakh language and comparing its results in healthy people and people with laryngopharyngeal reflux.


Recruitment information / eligibility

Status Completed
Enrollment 248
Est. completion date February 16, 2022
Est. primary completion date February 15, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 74 Years
Eligibility Inclusion Criteria: - Patient's informed consent; - Age: 18-74 years old; - No serious somatic diseases; - Patients with complaints of sore throat, coughing, burning sensation in the throat, coughing, frequent sore throat, difficulty swallowing, lump in the throat, foreign body feeling in the throat, voice changes, heartburn and belching; - Diagnosis: Chronic pharyngitis; - Chronic laryngitis. Exclusion Criteria: - Disagreement to participate in scientific research; - Age: under 18 and over 74; - Severe somatic diseases, organic lesions of the gastrointestinal tract and ENT organs; - Patients with pulmonary pathologies; - Patients with allergic manifestations (chronic or allergic rhinosinusitis and nasal polyposis); - With diagnoses: Acute respiratory diseases; - Patients with general neuralgic disorders; - Pregnancy; - Benign lesions of the vocal cords; - Acid-suppressive therapy within 4 weeks prior to recruitment

Study Design


Intervention

Other:
Reflux Symptom Index Inventory (diagnostic survey)
Kazakh versions of the Reflux Symptom Index Inventory will be filled patients
Reflux finding score
laryngoscopy with a score RFS

Locations

Country Name City State
Kazakhstan SOS Medical Assistance Almaty
Kazakhstan V-ent Almaty

Sponsors (2)

Lead Sponsor Collaborator
Kazakh Medical University of Continuing Education Asfendiyarov Kazakh National Medical University

Country where clinical trial is conducted

Kazakhstan, 

Outcome

Type Measure Description Time frame Safety issue
Primary RSI Score at Baseline: Patients will be asked to complete the Reflux Symptom Index questionnaire. An analysis of the results of the effectiveness of this method in patients with complaints of sore throat, coughing, burning sensation in the throat, cough, frequent sore throat, difficulty swallowing, lump in the throat, feeling of a foreign body in the throat, voice change, heartburn, belching will be carried out. The severity of the problem is calculated as the summation of all points. The problem is absent if the summation of points is 0. The problem is serious if the summation of points is 5. Total score ranges from 0-45; of which 0-12 is considered no laryngopharengeal reflux, above 13 points for the presence of laryngopharyngeal reflux. RSI Score at Baseline
Primary RSI Score at Days 10-14 Patients will be asked to complete the Reflux Symptom Index questionnaire. An analysis of the results of the effectiveness of this method in patients with complaints of sore throat, coughing, burning sensation in the throat, cough, frequent sore throat, difficulty swallowing, lump in the throat, feeling of a foreign body in the throat, voice change, heartburn, belching will be carried out. The severity of the problem is calculated as the summation of all points. The problem is absent if the summation of points is 0. The problem is serious if the summation of points is 5. Total score ranges from 0-45; of which 0-12 is considered no laryngopharengeal reflux, above 13 points for the presence of laryngopharyngeal reflux. Days 10-14
Primary RFS Score at Baseline: Device: Endoscopic laryngoscopy Video laryngoscopy and assessment of the presence / severity of the symptoms- Reflux finding score. Evaluation results range from 0 to 4, where 0 is an indicator of no problem, and 4 is an indicator of a serious problem. Total score ranges from 0-48; of which 0-6 is considered no laryngopharengeal reflux, above 7 points for the presence of laryngopharyngeal reflux. RFS Score at Baseline
Primary RFS Score at Days 10-14 Device: Endoscopic laryngoscopy Video laryngoscopy and assessment of the presence / severity of the symptoms - Reflux finding score and will be used as a gold standard of diagnosis of laryngopharengeal reflux. Evaluation results range from 0 to 4, where 0 is an indicator of no problem, and 4 is an indicator of a serious problem. Total score ranges from 0-48; of which 0-6 is considered no laryngopharengeal reflux, above 7 points for the presence of laryngopharyngeal reflux. Days 10-14
Primary Reliability and validity of RSI at Baseline: Reliability and validity of RSI at Baseline using Cronbach's alpha test to check the internal consistency for all the 9 items. Total score ranges from 0-45; of which 0-12 is considered no laryngopharengeal reflux, above 13 points for the presence of laryngopharyngeal reflux. RSI Score at Baseline
Primary Reliability and validity of RSI at Days 10-14. Reliability and validity of RSI at Days 10-14 using Cronbach's alpha test to check the internal consistency for all the 9 items. Total score ranges from 0-45; of which 0-12 is considered no laryngopharengeal reflux, above 13 points for the presence of laryngopharyngeal reflux. Days 10-14
Primary Laryngopharyngeal reflux diagnosis at baseline Video laryngoscopy and assessment of the presence / severity of the symptoms- Reflux finding score. Evaluation results range from 0 to 4, where 0 is an indicator of no problem, and 4 is an indicator of a serious problem. Total score ranges from 0-48; of which 0-6 is considered no laryngopharengeal reflux, above 7 points for the presence of laryngopharyngeal reflux. Baseline
Primary Laryngopharyngeal reflux diagnosis at Days 10-14. Video laryngoscopy and assessment of the presence / severity of the symptoms- Reflux finding score. Evaluation results range from 0 to 4, where 0 is an indicator of no problem, and 4 is an indicator of a serious problem. Total score ranges from 0-48; of which 0-6 is considered no laryngopharengeal reflux, above 7 points for the presence of laryngopharyngeal reflux. Days 10-14
Primary Test - retest reliability of the RSI questtionaire Test - retest reliability of the RSI questtionaire at Days 10-14. Test-retest reliability coefficients vary between 0 and 1, where:
1 : perfect reliability,
0.9: excellent reliability, 0.8 < 0.9: good reliability, 0.7 < 0.8: acceptable reliability, 0.6 < 0.7: questionable reliability, 0.5 < 0.6: poor reliability, < 0.5: unacceptable reliability, 0: no reliability. On this scale, a correlation of .9(90%) would indicate a very high correlation (good reliability) and a value of 10% a very low one (poor reliability).
Days 10-14
Primary Test - retest reliability of the RFS Test - retest reliability of the RFS questtionaire at Days 10-14. Test-retest reliability coefficients vary between 0 and 1, where:
1 : perfect reliability,
0.9: excellent reliability, 0.8 < 0.9: good reliability, 0.7 < 0.8: acceptable reliability, 0.6 < 0.7: questionable reliability, 0.5 < 0.6: poor reliability, < 0.5: unacceptable reliability, 0: no reliability. On this scale, a correlation of .9(90%) would indicate a very high correlation (good reliability) and a value of 10% a very low one (poor reliability).
Days 10-14
See also
  Status Clinical Trial Phase
Completed NCT04988347 - Spirulina Platensis for PPI Withdrawal Phase 2
Completed NCT03322553 - Endoscopic Full Thickness Plication (GERD-X) for the Treatment of PPI Dependent GERD: N/A
Recruiting NCT04884074 - Effect of Routine Anterior Crural Repair in De-Novo Gastroesophageal Reflux After Laparoscopic Sleeve Gastrectomy N/A
Enrolling by invitation NCT05678491 - Endoscopic Treatment of Gastroesophageal Reflux Disease N/A
Completed NCT01503476 - Development of Applications of the Bravo® pH Monitoring System and Evaluation of Its Performance Phase 4
Withdrawn NCT01788085 - Development of Applications of the Bravo® pH Monitoring System and Evaluation of Its Performance (Encore) N/A